Clinical Market Research Reports
Industry Standard Research – ISR Reports – is a full-service clinical market research company operating exclusively in the pharmaceutical and pharmaceutical services industry and a sister company of Clinical Leader. Their syndicated and custom market research capabilities enable their customers to make smarter, more informed business decisions. You’ll find links to their clinical trial market syndicated research reports below.
ISR's clinical market research reports are produced using direct feedback from decision-makers, which enables ISR to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to their customers. Each report is available to purchase online and you may also download free preview files. If you have any questions, please feel free to email info@ISRreports.com.
TRENDS AND MARKET OUTLOOK REPORTS
Phase I Market Outlook: 2022-2026
For this report, 125 Phase I decision-makers were surveyed to share their insights into where the Phase I market is now and what changes they expect over the next four years.
Phase II/III Market Outlook: 2022-2026
For this report, 132 Phase II/III decision-makers were surveyed to share their insights into where the Phase II/III market is now and what changes they expect over the next several years.
Clinical Logistics Market Dynamics
This report will bring you and your company up to speed on available clinical logistics offerings and different types of service providers’ use patterns that can help you make informed decisions.
Central Lab Benchmarking & Market Dynamics (2nd Ed.)
This report will help both study sponsors and providers answer a number of questions relevant to selecting and evaluating central lab service providers. For the purpose of this report, “central lab” is defined as a vendor that supplies specimen collection kits, logistics services, safety alerts, and a wide variety of laboratory testing services as well as providing lab reports to investigators.
2021 CRO Market Size & Growth Projections
This report gives quantitative insight into the perpetual question: “What is the size of the CRO market?” The data provide a thorough, rational perspective for clinical development services segmented by phase, geography, and service line.
Hybrid/Virtual/Decentralized Clinical Trials Market Outlook
For this report, ISR surveyed 109 respondents at sponsors and CROs regarding their experiences with hybrid trials and the providers of these services.
Clinical Development Outsourcing Models (4th Edition)
This market research report takes a look at user experiences with seven different clinical development outsourcing models.
Designing for Recruitment and Retention in Rare Disease Studies
This report takes a deep dive into two areas impacting the success of these studies: recruitment and retention. Given the importance of each rare disease patient, these activities are time-intensive and resource-heavy.
Clinical Manufacturing Market Dynamics and Service Provider Benchmarking
This report provides an overview of the current market dynamics in the clinical manufacturing space as well as an outlook of what our survey respondents predict the marketplace will look like in 2022.
Pharmacovigilance Market Dynamics and Service Provider Benchmarking (2nd edition)
ISR surveyed 100 decision-makers in the pharmacovigilance space to get insight on their experience regarding how their companies’ pharmacovigilance activities are split between processes, how much of their work is outsourced, and both in-house and outsourced personnel locations.
Site Start Up: Best Practices For Success
This report includes verbatim insights into the practices that create clinical site start up efficiency, the causes of inefficiency, and new practices being undertaken in an effort to improve efficiency. To get multiple perspectives on the site start up process, ISR surveyed people with site start up responsibilities at sponsors and CROs as well as people working at clinical sites, such as clinical investigators and study coordinators.
CRA Salary Analysis and Work Environment
Ask any HR manager working at a CRO or sponsor organization and they will tell you there is a war for talent when it comes to hiring and retaining high-quality CRAs. ISR decided to take a deep look at not only CRA salaries, but also signing bonuses, retention bonuses, raises, and turnover with the aim of benchmarking some industry trends. We collected data from 227 CRAs from various organizations and...
CRO QUALITY BENCHMARKING
Bioanalytical Labs Market Dynamics and Service Provider Performance (5th Ed.)
This report informs sponsors and providers of the current and anticipated future market dynamics for outsourced bioanalytical lab activities and includes performance evaluations from over 300 customer encounters with 20+ service providers.
Clinical Logistics Benchmarking
This report will give pharmaceutical companies and clinical logistics providers a comprehensive overview of outsourcing practices, in addition to a quantitative analysis of clinical logistics provider service quality across a series of 15 performance attributes specific to outsourced clinical logistics.
Phase I CRO Benchmarking (14th Ed.)
For this report, 186 experienced Phase I outsourcers shared their insights regarding 547 recent service provider encounters. It can help sponsors make more informed CRO selections, and can help CROs optimize operational and marketing strategies.
Phase II/III CRO Benchmarking (14th Edition)
This report is a resource for sponsor companies looking for information on CRO selection and performance. It includes insights from 229 Phase II/III outsourcers representing 776 service encounters.
Phase II/III CRO Benchmarking—Small Pharma Market (3rd Ed.)
This report can help small and emerging biopharma companies make more informed CRO selection decisions, and help CROs tailor their operational and marketing strategies to address the unique needs of up-and-coming drug innovators.
CRO Quality Benchmarking – Phase IV Service Providers (12th Edition)
The goal of this market research report is to provide detailed information to aid in making informed decisions when outsourcing Phase IV work. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access...
CTMS Benchmarking & Market Dynamics (3rd Ed.)
ISR surveyed 121 qualified CTMS decision makers to get their insights on the importance of various attributes in selecting a CTMS provider as well as their satisfaction with the performance of various CTMS providers against those same attributes.
EDC Market Dynamics and Service Provider Performance (4th Edition)
This market research report examines the industry perception of the EDC market based on the responses of 132 industry professionals experienced with these systems. ISR has asked respondents how their respective companies handle the decisions associated with outsourcing these systems as well as how they would prefer the outsourcing be...
IRT Market Dynamics and Service Provider Benchmarking (3rd edition)
This market research report covers the state of the IRT and its apparent transition from standalone point products to more fully integrated systems that use and feed data into other eClinical systems such as EDC systems, CTMS, and eCOA systems, in addition to managing randomization and drug supply functions.
eTMF Market and Service Provider Dynamics (2nd edition)
Study sponsors and CROs can use this report for insight into user experience/satisfaction with leading eTMF software providers to inform their vendor selection process, and eTMF providers can use it to better understand their own strengths and weaknesses - and those of their competitors.
mHealth In Clinical Trials: Current Status/Future Projections
For this study, Industry Standard Research (ISR) collected both qualitative and quantitative data. Qualitative telephone interviews were used to gain insight into mHealth expert viewpoints, while a quantitative, internet-based survey was used to collect hard data on familiarity with mHealth, anticipated implementation, and usage rates in recent or soon-to-be conducted clinical trials.
Risk-Based Monitoring: Improving the Clinical Trial Site Experience
Technology forges a world where human connection is no longer inhibited by distance. Barriers are broken and replaced with virtual bridges that create unprecedented potential for an interconnected present and future. And no doubt the areas most affected by this technological nexus are ones dominated by human synergy. An area at...
DEPARTMENT MODELS AND STRUCTURES
Safety and Pharmacovigilance: Department Models and Structures
ISR conducted 11 in-depth interviews with tenured post-marketing safety and pharmacovigilance professionals from leading biotechnology and pharmaceutical companies in North America and Europe.
Managed Markets: Department Models and Structures
For this report, ISR conducted interviews with a cross-section of executive, director, and managerial level MM professionals from large, mid-size, and small pharmaceutical and biotech companies to gain a better understanding of managed markets departments, how they work, and the challenges they face.
Benchmarking The Pharma Industry’s Medical Science Liaison (MSL) Function
This market research report has been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within...
Industry Trends: CDMO Outsourcing
No single CDMO strategy or outsourcing model is appropriate for every project. Outsourcers can and should evaluate a strategy and partner(s) on a case-by-case basis.
Phase II/III Outsourcing Partner Selection Attributes
In the beginning of 2022, ISR surveyed 132 sponsors worldwide who outsource Phase II/III studies and asked them to identify attributes that are important to them when selecting an outsourcing partner. The research revealed that respondents valued operational excellence and therapeutic expertise highly when choosing a provider for their Phase II/III studies.
Understanding The Art And Science Of CRO Selection
This e-book examines the rationale behind how CROs are selected, why they are retained, and why sponsors opt for one provider or outsourcing model versus another.
2022 CRO Leadership Awards Results
50 CROs were evaluated on more than 20 performance metrics. Research participants were recruited from biopharmaceutical companies of all sizes and were screened for decision-making influence when it comes to working with outsourcing partners. Find out the results in this report.
Industry Trends: Clinical Logistics Outsourcing
Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
CEO KEVIN OLSON INTRODUCES YOU TO INDUSTRY STANDARD RESEARCH
ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive:
- Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
- Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries. We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
- Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.
For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.